Literature DB >> 28685575

Biodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo.

Xinfu Zhang, Bin Li, Xiao Luo, Weiyu Zhao, Justin Jiang, Chengxiang Zhang, Min Gao1, Xiaofang Chen, Yizhou Dong.   

Abstract

Efficient and safe delivery of the CRISPR/Cas system is one of the key challenges for genome-editing applications in humans. Herein, we designed and synthesized a series of biodegradable lipidlike compounds containing ester groups for the delivery of mRNA-encoding Cas9. Two lead materials, termed N-methyl-1,3-propanediamine (MPA)-A and MPA-Ab, showed a tunable rate of biodegradation. MPA-A with linear ester chains was degraded dramatically faster than MPA-Ab with branched ester chains in the presence of esterase or in wild-type mice. Most importantly, MPA-A and MPA-Ab demonstrated efficient delivery of Cas9 mRNA both in vitro and in vivo. Consequently, these biodegradable lipidlike nanomaterials merit further development as genome-editing delivery tools for biological and therapeutic applications.

Entities:  

Keywords:  CRISPR/Cas9; biodegradable nanomaterials; genome editing; lipidlike nanoparticles; mRNA

Mesh:

Substances:

Year:  2017        PMID: 28685575      PMCID: PMC5896755          DOI: 10.1021/acsami.7b08163

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  33 in total

1.  Lipid-like materials for low-dose, in vivo gene silencing.

Authors:  Kevin T Love; Kerry P Mahon; Christopher G Levins; Kathryn A Whitehead; William Querbes; J Robert Dorkin; June Qin; William Cantley; Liu Liang Qin; Timothy Racie; Maria Frank-Kamenetsky; Ka Ning Yip; Rene Alvarez; Dinah W Y Sah; Antonin de Fougerolles; Kevin Fitzgerald; Victor Koteliansky; Akin Akinc; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

Review 2.  Safety profile of RNAi nanomedicines.

Authors:  Scott A Barros; Jared A Gollob
Journal:  Adv Drug Deliv Rev       Date:  2012-06-22       Impact factor: 15.470

3.  Direct observation of liquid crystals using cryo-TEM: specimen preparation and low-dose imaging.

Authors:  Min Gao; Young-Ki Kim; Cuiyu Zhang; Volodymyr Borshch; Shuang Zhou; Heung-Shik Park; Antal Jákli; Oleg D Lavrentovich; Maria-Gabriela Tamba; Alexandra Kohlmeier; Georg H Mehl; Wolfgang Weissflog; Daniel Studer; Benoît Zuber; Helmut Gnägi; Fang Lin
Journal:  Microsc Res Tech       Date:  2014-07-05       Impact factor: 2.769

4.  Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.

Authors:  Yizhou Dong; Kevin T Love; J Robert Dorkin; Sasilada Sirirungruang; Yunlong Zhang; Delai Chen; Roman L Bogorad; Hao Yin; Yi Chen; Arturo J Vegas; Christopher A Alabi; Gaurav Sahay; Karsten T Olejnik; Weiheng Wang; Avi Schroeder; Abigail K R Lytton-Jean; Daniel J Siegwart; Akin Akinc; Carmen Barnes; Scott A Barros; Mary Carioto; Kevin Fitzgerald; Julia Hettinger; Varun Kumar; Tatiana I Novobrantseva; June Qin; William Querbes; Victor Koteliansky; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

Review 5.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

6.  An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.

Authors:  Bin Li; Xiao Luo; Binbin Deng; Junfeng Wang; David W McComb; Yimin Shi; Karin M L Gaensler; Xu Tan; Amy L Dunn; Bryce A Kerlin; Yizhou Dong
Journal:  Nano Lett       Date:  2015-11-06       Impact factor: 11.189

7.  Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo.

Authors:  Yizhou Dong; Ahmed A Eltoukhy; Christopher A Alabi; Omar F Khan; Omid Veiseh; J Robert Dorkin; Sasilada Sirirungruang; Hao Yin; Benjamin C Tang; Jeisa M Pelet; Delai Chen; Zhen Gu; Yuan Xue; Robert Langer; Daniel G Anderson
Journal:  Adv Healthc Mater       Date:  2014-03-13       Impact factor: 9.933

8.  In vivo genome editing using Staphylococcus aureus Cas9.

Authors:  F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

9.  Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos.

Authors:  Nannan Chang; Changhong Sun; Lu Gao; Dan Zhu; Xiufei Xu; Xiaojun Zhu; Jing-Wei Xiong; Jianzhong Jeff Xi
Journal:  Cell Res       Date:  2013-03-26       Impact factor: 25.617

10.  Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.

Authors:  Hao Yin; Chun-Qing Song; Joseph R Dorkin; Lihua J Zhu; Yingxiang Li; Qiongqiong Wu; Angela Park; Junghoon Yang; Sneha Suresh; Aizhan Bizhanova; Ankit Gupta; Mehmet F Bolukbasi; Stephen Walsh; Roman L Bogorad; Guangping Gao; Zhiping Weng; Yizhou Dong; Victor Koteliansky; Scot A Wolfe; Robert Langer; Wen Xue; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

View more
  19 in total

Review 1.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

2.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

3.  Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer.

Authors:  Chengxiang Zhang; Xinfu Zhang; Weiyu Zhao; Chunxi Zeng; Wenqing Li; Bin Li; Xiao Luo; Junan Li; Justin Jiang; Binbin Deng; David W McComb; Yizhou Dong
Journal:  Nano Res       Date:  2019-02-01       Impact factor: 8.897

4.  Co-delivery of mRNA and SPIONs through amino-ester nanomaterials.

Authors:  Xiao Luo; Weiyu Zhao; Bin Li; Xinfu Zhang; Chengxiang Zhang; Anna Bratasz; Binbin Deng; David W McComb; Yizhou Dong
Journal:  Nano Res       Date:  2018-05-12       Impact factor: 8.897

Review 5.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

6.  Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.

Authors:  Melissa P Lokugamage; Daryll Vanover; Jared Beyersdorf; Marine Z C Hatit; Laura Rotolo; Elisa Schrader Echeverri; Hannah E Peck; Huanzhen Ni; Jeong-Kee Yoon; YongTae Kim; Philip J Santangelo; James E Dahlman
Journal:  Nat Biomed Eng       Date:  2021-10-06       Impact factor: 25.671

Review 7.  Nanoscale platforms for messenger RNA delivery.

Authors:  Bin Li; Xinfu Zhang; Yizhou Dong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-04

8.  Computational and Experimental Approaches to Investigate Lipid Nanoparticles as Drug and Gene Delivery Systems.

Authors:  Chun Chan; Shi Du; Yizhou Dong; Xiaolin Cheng
Journal:  Curr Top Med Chem       Date:  2021       Impact factor: 3.295

9.  Lipid Polymer Hybrid Nanomaterials for mRNA Delivery.

Authors:  Weiyu Zhao; Chengxiang Zhang; Bin Li; Xinfu Zhang; Xiao Luo; Chunxi Zeng; Wenqing Li; Min Gao; Yizhou Dong
Journal:  Cell Mol Bioeng       Date:  2018-06-19       Impact factor: 2.321

Review 10.  Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing.

Authors:  Li Duan; Kan Ouyang; Xiao Xu; Limei Xu; Caining Wen; Xiaoying Zhou; Zhuan Qin; Zhiyi Xu; Wei Sun; Yujie Liang
Journal:  Front Genet       Date:  2021-05-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.